Establishment of a Predictive Model for Post-dural Puncture Headache

January 23, 2025 updated by: Yilin Zhao, YiLin Zhao

The goal of this clinical trial is to establish a predictive model for post-dural puncture headache. The main questions it aims to answer are:

Changes in intracranial pressure after spinal puncture (or lumbar puncture). When post-dural puncture headache occurs, the optic nerve sheath diameter (ONSD) change When the optic nerve sheath diameter (ONSD) and (or) Intraocular Pressure (IOP) reaches a certain threshold, does proactive treatment reduce the incidence of postoperative headaches? Researchers will measure the optic nerve sheath diameter (ONSD) using ultrasound and ( or ) magnetic resonance imaging (MRI) before and after spinal puncture.

Researchers will measure the Intraocular Pressure (IOP) using ICARE before and after spinal puncture.

Participants will:

Undergo ultrasound and (or) magnetic resonance imaging (MRI) examinations before and after spinal puncture Undergo ICARE examinations before and after spinal puncture

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Detailed Description

Post-dural Puncture Headache (PDPH) refers to a specific type of headache that occurs after patients receive intrathecal anesthesia or a lumbar puncture, resulting from the leakage of cerebrospinal fluid (CSF) due to the puncture of the dura mater and arachnoid mater. This type of headache typically occurs within 24 to 48 hours after the puncture and is characterized primarily by positional headaches, meaning that the headache worsens when the patient is standing or sitting and improves when lying down. The headache is often accompanied by symptoms such as neck stiffness, nausea, vomiting, tinnitus, and blurred vision.

The primary mechanism of PDPH is the leakage of cerebrospinal fluid from the puncture site after the dura and arachnoid are punctured, leading to a decrease in CSF pressure. The reduction in cerebrospinal fluid can cause several physiological changes:Decreased CSF Pressure: The reduction of CSF leads to a drop in intracranial pressure, which alters the mechanisms that support the brain, resulting in pain.Meningeal Tension: The decrease in CSF may cause tension on the meninges and nerve roots, leading to pain sensations.Vasodilation: The drop in intracranial pressure can trigger a reflexive dilation of cerebral blood vessels, further exacerbating the pain.The incidence of PDPH is associated with various factors, including the patient's age, sex, body type, type of surgery performed, and the type and size of the puncture needle used. Smaller needles (such as 25G or thinner) and non-cutting needles (such as Sprotte needles) can significantly reduce the incidence of PDPH, whereas larger and cutting needles (such as Quincke needles) are associated with a higher incidence. Younger patients and females are more prone to developing PDPH. Additionally, multiple punctures increase the risk of PDPH.

Timely and effective treatment can significantly reduce the occurrence of PDPH; however, there is currently a lack of monitoring methods for PDPH. This study aims to establish a predictive model for the occurrence of PDPH by measuring postural cerebrospinal fluid pressure using ultrasound, which can enable early prediction and treatment of PDPH, thereby significantly improving patient comfort and recovery processes.

The goal of this clinical trial is to establish a predictive model for post-dural puncture headache,with the goal of implementing proactive interventions and treatments to reduce the incidence of PDPH and improve clinical management. Therefore, establishing an effective early warning model is crucial Participants will receive ultrasound, magnetic resonance imaging (MRI) and (or ) ICARE examinations before and after spinal puncture

Study Type

Observational

Enrollment (Estimated)

480

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430030
        • Tongji Hospital of Tongji Medical College of Huazhong Universtiy of Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients who need dural puncture

Description

Inclusion Criteria:

BMI ≤ 30 kg/m² Normal liver and kidney function before surgery Normal coagulation function before surgery Hemoglobin > 70 g/L Platelet count > 80 × 10⁹/L

Exclusion Criteria:

Patients who experience major bleeding during or after surgery Patients with cerebrospinal fluid leakage or other serious malformations Patients with mental health disorders or cognitive dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
No Post-dural Puncture Headache Group in adult
Perform MRI and (or) ultrasound and (or) intraocular pressure measurement before and 24 hours after the puncture
Post-dural Puncture Headache Group in adult
Perform MRI and (or) ultrasound and (or) intraocular pressure measurement before and 24 hours after the puncture
To ensure optimal recovery and manage potential complications, patients are advised to supplement fluids by increasing their oral intake or receiving intravenous fluids as necessary. Bed rest is recommended to reduce physical strain and promote healing. Additionally, a blood patch procedure may be performed to alleviate symptoms such as headaches that can occur after certain medical procedures, particularly spinal taps. This involves injecting a small amount of the patient's own blood into the epidural space to seal any leaks of cerebrospinal fluid, thereby providing relief and aiding in recovery. Proper monitoring and follow-up care are essential to ensure the effectiveness of these interventions
Other Names:
  • Blood patch
  • Bed rest
No Post-dural Puncture Headache Group in children
Perform MRI and (or) ultrasound and (or) intraocular pressure measurement before and 24 hours after the puncture
Post-dural Puncture Headache Group in children
Perform MRI and (or) ultrasound and (or) intraocular pressure measurement before and 24 hours after the puncture
To ensure optimal recovery and manage potential complications, patients are advised to supplement fluids by increasing their oral intake or receiving intravenous fluids as necessary. Bed rest is recommended to reduce physical strain and promote healing. Additionally, a blood patch procedure may be performed to alleviate symptoms such as headaches that can occur after certain medical procedures, particularly spinal taps. This involves injecting a small amount of the patient's own blood into the epidural space to seal any leaks of cerebrospinal fluid, thereby providing relief and aiding in recovery. Proper monitoring and follow-up care are essential to ensure the effectiveness of these interventions
Other Names:
  • Blood patch
  • Bed rest

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Optic nerve sheath diameter (ONSD) measurement by MRI
Time Frame: 1 hour before dural puncture
ONSD Measurement by MRI
1 hour before dural puncture
Optic nerve sheath diameter (ONSD) measurement by MRI
Time Frame: 24 hours after dural puncture
ONSD Measurement by MRI
24 hours after dural puncture
Optic nerve sheath diameter (ONSD) measurement by B ultrasound
Time Frame: 1 hour before dural puncture
ONSD Measurement by B ultrasound
1 hour before dural puncture
Optic nerve sheath diameter (ONSD) measurement by B ultrasound
Time Frame: 8 hours after dural puncture
ONSD Measurement by B ultrasound
8 hours after dural puncture
Optic nerve sheath diameter (ONSD) measurement by B ultrasound
Time Frame: 24 hours after dural puncture
ONSD Measurement by B ultrasound
24 hours after dural puncture
Optic nerve sheath diameter (ONSD) measurement by B ultrasound
Time Frame: 48 hours after dural Puncture
ONSD Measurement by B ultrasound
48 hours after dural Puncture
Intraocular Pressure messurement
Time Frame: 1 Hour before dural Puncture
Intraocular Pressure measurement by Icare
1 Hour before dural Puncture
Intraocular Pressure messurement
Time Frame: 8 hours after dural puncture
Intraocular Pressure measurement by Icare
8 hours after dural puncture
Intraocular Pressure messurement
Time Frame: 24 hours after dural puncture
Intraocular Pressure measurement by Icare
24 hours after dural puncture
Intraocular Pressure messurement
Time Frame: 48 hours after dural puncture
Intraocular Pressure measurement by Icare
48 hours after dural puncture

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of punctures
Time Frame: 24 hours after dural puncture
number of punctures
24 hours after dural puncture
type of puncture needle
Time Frame: 24 hours after dural puncture
type of puncture needle
24 hours after dural puncture
Onset time of postoperative headache and duration
Time Frame: 24 hours after dural puncture
Onset time of postoperative headache" and "duration
24 hours after dural puncture

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Yilin Zhao, Huazhong Universty of Science and Technology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 20, 2025

Primary Completion (Estimated)

May 20, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

January 17, 2025

First Submitted That Met QC Criteria

January 23, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 23, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal and Epidural Anaesthesia-Induced Headache During Pregnancy

Clinical Trials on Supplement fluids

Subscribe